Related Experiment Video

Updated: Jul 10, 2026

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Dual level inhibition of E2F-1 activity by adeno-associated virus Rep78

R B Batchu1, M A Shammas, J Y Wang

  • 1Central Arkansas Veterans Health Care System and Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.

The Journal of Biological Chemistry
|April 11, 2001
PubMed

Insights

Adeno-associated virus-2 (AAV) protein Rep78 has onco-suppressive properties. Rep78 stabilizes the retinoblastoma protein-E2F-1 complex and down-regulates E2F-1 transcription, reducing cell proliferation.

Area of Science:

  • Molecular biology
  • Virology
  • Oncology

Background:

  • E2F-1 is a key cell cycle regulator.
  • Retinoblastoma protein (pRB) inhibits E2F-1 activity.
  • Disruption of the pRB-E2F-1 complex promotes cell proliferation and is linked to DNA tumor viruses.

Purpose of the Study:

  • To elucidate the molecular mechanisms behind the onco-suppressive properties of Adeno-associated virus-2 (AAV).
  • To investigate the role of AAV protein Rep78 in regulating the pRB-E2F-1 complex and cell cycle control.

Main Methods:

  • Protein-protein interaction studies to assess Rep78's effect on the pRB-E2F-1 complex.
  • DNA-binding assays to determine Rep78's interaction with the E2F-1 promoter.
  • Analysis of E2F-1 transcription levels and cellular E2F-1 protein levels.

Main Results:

  • AAV Rep78 protein directly interacts with E2F-1.
  • Rep78 stabilizes the pRB-E2F-1 complex, preventing E2F-1-mediated cell proliferation.
  • Rep78 binds to the E2F-1 promoter, down-regulating its transcription, particularly in adenovirus-infected cells.
  • These actions lead to reduced levels of free E2F-1 in cells.

Conclusions:

  • AAV Rep78 exhibits dual-level regulation of E2F-1: protein stabilization and transcriptional repression.
  • This dual mechanism underlies AAV's onco-suppressive activity against DNA tumor viruses.
  • Rep78 represents a potential therapeutic target for controlling viral oncogenesis.

More Related Videos

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells10:22

Isolation of Viral Replication Compartment-enriched Sub-nuclear Fractions from Adenovirus-infected Normal Human Cells

Published on: November 12, 2015

Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...